AxisBiotix-Ps™
Psoriasis symptom management
CommercialActive
Key Facts
About SkinBioTherapeutics
SkinBioTherapeutics leverages its proprietary SkinBiotix® platform, based on microbiome science from The University of Manchester, to develop products for skin health. The company has transitioned from R&D to early commercialization with its AxisBiotix-Ps™ supplement for psoriasis and has expanded its asset base through strategic acquisitions like Dermatonics and Bio-Tech Solutions. It is targeting a diversified portfolio across cosmetic, supplement, medical device, hygiene, and pharmaceutical sectors, positioning itself at the intersection of consumer health and dermatology.
View full company profile